1 results match your criteria: "University of Calgary Infection Prevention and Control[Affiliation]"
Differences of the Fecal Microflora With Clostridium difficile Therapies.
Clin Infect Dis
May 2015
Department of Medicine and Department of Microbiology, Immunology and Infectious Diseases, University of Calgary Infection Prevention and Control, Calgary Zone, Alberta Health Services, Canada.
Background: During treatment of Clostridium difficile infection (CDI), patterns of pathogen reduction in relationship to changes in components of the normal microbiota are hypothesized to be predictive of response to treatment and subsequent sustained cure.
Methods: At a single center, subjects enrolled into phase 2 and 3 C. difficile treatment clinical trials (2003-2008) provided fecal samples to assess killing of C.